OTCMKTS:MXDHF MDxHealth (MXDHF) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MXDHF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.25▼$2.5052-Week Range N/AVolume300 shsAverage Volume1,000 shsMarket Capitalization$3.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get MDxHealth alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About MDxHealth Stock (OTCMKTS:MXDHF)MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. MXDHF Stock News HeadlinesMarch 7, 2024 | finance.yahoo.comMDxHealth SA (NASDAQ:MDXH) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | markets.businessinsider.comThese Analysts Increase Their Forecasts On MDxHealth After Q4 ResultsApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 2, 2024 | benzinga.comMVM Partners, LLC's Net WorthFebruary 16, 2024 | markets.businessinsider.comMdxhealth Announces Resignation of Board MemberFebruary 9, 2024 | morningstar.comCrexendo Inc CXDODecember 17, 2023 | finance.yahoo.comMDxHealth SA (MDXH.BR)November 27, 2023 | benzinga.comMDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on NasdaqApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. November 14, 2023 | finance.yahoo.comMDxHealth to Participate in the 35th Annual Piper Sandler Healthcare ConferenceNovember 12, 2023 | morningstar.comThinking about buying stock in Generation Bio, Blink Charging, MDxHealth, Microvast Holdings, or Crexendo?October 25, 2023 | finance.yahoo.comMDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8October 9, 2023 | finance.yahoo.comMDxHealth Reports Preliminary Q3-2023 RevenuesOctober 2, 2023 | finance.yahoo.comMDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders MeetingAugust 24, 2023 | finanznachrichten.demdxhealth: MDxHealth Reports Q2 and Half Year 2023 ResultsAugust 10, 2023 | finance.yahoo.comMDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23August 9, 2023 | finance.yahoo.comCigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer TestJuly 1, 2023 | finanznachrichten.demdxhealth: MDxHealth Announces Results of its Extraordinary General Shareholders' MeetingApril 26, 2023 | wsj.comMDxHealth S.A. ADRFebruary 3, 2023 | finance.yahoo.comMDxHealth Announces Pricing of Offering of ADSs in the United StatesNovember 30, 2022 | finance.yahoo.comMDxHealth Provides Business UpdateOctober 27, 2022 | nz.finance.yahoo.comMDxHealth Reports Q3-2022 ResultsAugust 25, 2022 | ca.finance.yahoo.comMDxHealth Reports Half Year 2022 ResultsMay 25, 2022 | finance.yahoo.comMDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings and Resignation of DirectorApril 27, 2022 | uk.finance.yahoo.comMDxHealth Reports Q1-2022 ResultsMarch 30, 2022 | tmcnet.comMDxHealth to Participate in the 14th Annual Kempen Life Sciences ConferenceMarch 3, 2022 | finance.yahoo.comMDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022See More Headlines Receive MXDHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:MXDHF Previous SymbolNASDAQ:MXDHF CUSIPN/A CIKN/A Webwww.mdxhealth.com Phone(324) 257-7071Fax32042597875Employees252Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.45 Current Ratio1.25 Quick Ratio1.19 Sales & Book Value Annual Sales$37.05 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.60 per share Price / BookN/AMiscellaneous Outstanding Shares15,597,000Free Float15,332,000Market Cap$3.90 million OptionableNot Optionable Beta1.46 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Michael K. McGarrity (Age 60)CEO & Executive Director Comp: $564.23kMr. Ron Kalfus (Age 49)Chief Financial Officer Mr. Joseph Sollee (Age 58)Executive VP of Corporate Development & General Counsel Mr. John A. Bellano (Age 54)Chief Commercial Officer Ms. Miriam Reyes (Age 50)Executive Vice President of Operations Dr. Wim Van Criekinge (Age 51)Chief Scientific Officer More ExecutivesKey CompetitorsPreveCeutical MedicalOTCMKTS:PRVCFCatheter PrecisionNYSEAMERICAN:VTAKXylo TechnologiesNASDAQ:MDGSSeelos TherapeuticsNASDAQ:SEELHelius Medical TechnologiesNASDAQ:HSDTView All Competitors MXDHF Stock Analysis - Frequently Asked Questions How do I buy shares of MDxHealth? Shares of MXDHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MXDHF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
